Related Experiment Video
Updated: Nov 7, 2025

08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.7K
Biomarkers for Cancer Cachexia: A Mini Review.
Zhipeng Cao1, Kening Zhao1,2, Irvin Jose1
1Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia.
International Journal of Molecular Sciences
|April 30, 2021
Summary
Cancer cachexia biomarkers are crucial for early diagnosis and treatment assessment. Identifying these markers using "omics approaches" aids in managing this complex cancer complication.
Area of Science:
- Oncology
- Biochemistry
- Genomics
Background:
- Cancer cachexia significantly impacts cancer patient prognosis and treatment tolerance.
- Current diagnostic methods rely on late-stage indicators like body mass loss.
- There is a critical need for early diagnostic and treatment efficacy biomarkers.
Purpose of the Study:
- To review and summarize current research on cancer cachexia biomarkers.
- To highlight the potential of
Main Methods:
- Literature review of studies identifying cancer cachexia biomarkers.
- Analysis of high-throughput
Main Results:
- Numerous potential biomarkers for cancer cachexia have been identified using
Conclusions:
- Biomarkers are essential for early cancer cachexia detection and monitoring treatment response.
- Further research is needed to validate identified biomarkers and establish treatment efficacy standards.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
303
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
303
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
486
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
486

